Gsa Capital Partners LLP Neogenomics Inc Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$11.67 - $20.73 $133,959 - $237,959	11,479 New	11,479 $185,000
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $190,426 - $407,458	20,949 New	20,949 $364,000
Q2 2021 Aug 05, 2021	SELL	$36.62 - $51.69 $192,731 - $272,044	-5,263 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$41.56 - $59.88 $218,730 - $315,148	5,263 New	5,263 $254,000
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $670,674 - $1.13 Million	-55,245 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$11.24 - $18.5 $620,953 - $1.02 Million	55,245 New	55,245 $697,000
Q4 2017 Feb 14, 2018	SELL	$8.02 - $11.18 $266,191 - $371,075	-33,191 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$9.11 - $11.26 $302,370 - $373,730	33,191	33,191 $369,000

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.